Oncology Central

Engulfing losers by winners in cancer: do cancer stem cells catch eat-me signals from noncancer stem cells?


Each year, more than 1.6 million people in the USA are diagnosed with new cancers, and this number has been continuously increasing for decades. Most of the targeted therapeutics tested thus far have shown little or limited sustained survival benefit. The failure to achieve a cure may include the presence of self-renewing, highly tumorigenic cancer stem cells (CSCs) contributing to therapeutic resistance and invasion into normal tissues. Targeting CSCs is probably mandated to inhibit tumor growth and sensitize tumors to conventional therapies. In a tumor mass, however, CSCs are tightly associated with other cells including non-CSCs and stromal cells.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.